Correlation Between Oncorus and Pyxis Oncology
Can any of the company-specific risk be diversified away by investing in both Oncorus and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Pyxis Oncology, you can compare the effects of market volatilities on Oncorus and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Pyxis Oncology.
Diversification Opportunities for Oncorus and Pyxis Oncology
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Oncorus and Pyxis is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Oncorus i.e., Oncorus and Pyxis Oncology go up and down completely randomly.
Pair Corralation between Oncorus and Pyxis Oncology
If you would invest 4.35 in Oncorus on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Oncorus or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
Oncorus vs. Pyxis Oncology
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pyxis Oncology |
Oncorus and Pyxis Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Pyxis Oncology
The main advantage of trading using opposite Oncorus and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Pyxis Oncology vs. Zura Bio Limited | Pyxis Oncology vs. Altamira Therapeutics | Pyxis Oncology vs. Elevation Oncology | Pyxis Oncology vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |